After DNA damage, TP53 can reprogram the energy generation strategy of cells from glycolysis to mitochondrial respiration (or oxidative phosphorylation) to inhibit the development of diabetes (Kruiswijk et al., 2015). Here, TP53 is linked to diabetes mellitus.